Articles

2009 has started with a bang...

The National Neurovision Research Institute (NNRI) in the US and Adeona Pharmaceuticals Inc. have announced a collaboration to investigate the oral drug flupirtine in the treatment of retinitis pigmentosa (RP).

Dr Richard Kaiser outlines the recommendations of the microsurgical safety task force.

Abbott acquires AMO, Alcon gains new CEO…

Professor Scott Cousins explains how we can use our knowledge of drusen formation to find new ways to combat dry age-related macular degeneration.

Investigation of the association between 677C>T and 1298A>C 5,10-methylenetetra- hydrofolate reductase gene polymorphisms and normal-tension glaucoma

ISTA Pharmaceuticals' dry eye candidate, ecabet sodium, has successfully completed Phase IIb testing and will soon be progressing to Phase III trials taking it a step closer to regulatory approval.

Lucentis (ranibizumab; Novartis) has been approved for the treatment of wet age-related macular degeneration (AMD) in Japan, Novartis has announced.

GlaucomaCheck, an online visual field test allowing for clinical grade at-home glaucoma screening, has been launched by VisionRx.

Former US President Jimmy Carter has dedicated a statue representing the "Gift of Sight" to the Lions Clubs International in Oak Brook, Illinois.

Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil

Immediate vs delayed sequential cataract surgery: a comparative study

Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects

The Cataract National Dataset electronic multicentre audit of 55 567 operations: risk stratification for posterior capsule rupture and vitreous loss

The Vision Care for Kids Bill of 2009, legislation to provide vision care to children without health insurance, has been introduced in the US after being approved both by the Senate and by the House of Representatives.

A team in the Philippines has defined criteria that need to be met in order to obtain an optimum tissue quality for corneal grafts.

ASP-440 - a protease, developed by ActiveSite Pharmaceuticals and an inhibitor of plase kallikrein - may provide an effective therapeutic treatment for diabetic retinopathy (DR), according to study results published in the February 2009 issue of Hypertension.

Assessing Quality of Life in Patients With Glaucoma Using the Glaucoma Quality of Life-15 (GQL-15) Questionnaire

Generation of immature retinal neurons from proliferating cells in the pars plana after retinal histogenesis in mice with retinal degeneration

Iplex (mecasermin rinfabate), a complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its predominant binding protein IGFBP-3 (rhIGFBP-3) developed for the treatment of retinopathy of prematurity (ROP), has been granted orphan drug designation by the EMEA, according to a statement from Iplex developers Insmed Inc and Premacure AB.

Phacoemulsification can increase visual acuity in uveitis patients, concluded a study published in the January issue of the British Journal of Ophthalmology.

Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension

Relationship between refraction and allergic conjunctivitis

The Importance of Early Diagnosis of Acute Retinal Necrosis Syndrome

ONE-YEAR FOLLOW-UP OF COMBINED CUSTOMIZED THERAPY. PHOTODYNAMIC THERAPY AND BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Combined Pars Plana Lensectomy/Vitrectomy for Idiopathic Macular Hole Repair Without Postoperative Prone Positioning

The Tecnis multifocal intraocular lens (IOL) has been approved by the FDA, according to an announcement made by AMO, the manufacturer of the lens.

Correlation Between Corneal and Scleral Thickness in Glaucoma

MacuCLEAR and Mystic Pharmaceuticals are to collaborate on MacuCLEAR's upcoming Phase I/II trials of MC 1101 for the treatment and prevention of progression of dry age-related macular degeneration (AMD).